17 results
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... amphotericin B, 3 to 5 mg/kg ... IDSA #Prevention #Treatment ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
HIV-AIDS Preventing Clinical ... and preventing clinical ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
Neck: “dropping ... Serologic and EMG ... stimulation - Single fiber ... precipitated by: Drugs, infection ... Gravis #diagnosis #management
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
other factors (e.g ... retinitis, is no longer ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
amphotericin B 3–5 mg/kg ... • Use until clinical ... IDSA #Prevention #Treatment ... #management #opportunistic ... #pharmacology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
response preceding infection ... meningococcal, H1N1) Clinical ... Guillain-Barre Clinical ... Syndrome #diagnosis #management ... #treatment #neurology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
acyclovir 5 mg/kg ... • Continue treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... #pharmacology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
by 24 hours or longer ... Preeclampsia, Eclampsia, Infection ... Diagnosis: • Infection ... epilepticus Treatment ... Syndrome #diagnosis #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
auscultation, JVD ... ECG is vital while ... & Dry) is the treatment ... differential #algorithm #management ... #pharmacology